NEWS
                                                      NEWS

                                                      Industry News
                                                      NEWS

                                                      NEWS
                                                      FDA Approved Drugs for Oncology

                                                      TIME:2016/7/14 9:18:24 SOURSE:

                                                      Farydak (panobinostat); Novartis; For the treatment of multiple myeloma, Approved February 2015


                                                      Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015


                                                      Lenvima (lenvatinib); Eisai; For the treatment of thyroid cancer, Approved February 2015


                                                      Opdivo (nivolumab); Bristol-Myers Squibb; For the treatment of metastatic squamous non-small cell lung cancer, Approved March 2015


                                                      Unituxin (dinutuximab); United Therapeutics; For the treatment of pediatrics with high-risk neuroblastoma, Approved March 2015


                                                      The article was refered to: https://www.centerwatch.com/drug-information/fda-approved-drugs/therapeutic-area/12/oncology

                                                      Copyright  Bayeebio Biotech (Shanghai) Co., Ltd. Shanghai  滬ICP備16015574號

                                                      亚洲综合无码一区二区三区伊人| 亚洲VA中文字幕无码一二三区| 国产伦精品视频一区二区三区经| 国产亚洲不卡二卡三卡四卡免费